The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder.

Saved in:
Bibliographic Details
Title: The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder.
Authors: Varodayan FP; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Developmental Exposure Alcohol Research Center and Behavioral Neuroscience Program, Department of Psychology, Binghamton University, State University of New York, Binghamton, New York., Patel RR; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Systems Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, California., Matzeu A; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Wolfe SA; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Curley DE; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island; Neuroscience Graduate Program, Department of Neuroscience, Brown University, Providence, Rhode Island., Khom S; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Gandhi PJ; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Rodriguez L; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Bajo M; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., D'Ambrosio S; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Sun H; Clinical Core Laboratory, Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Kerr TM; College of Pharmacy, Division of Pharmacology and Toxicology, University of Texas at Austin, Austin, Texas., Gonzales RA; College of Pharmacy, Division of Pharmacology and Toxicology, University of Texas at Austin, Austin, Texas., Leggio L; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland; Medication Development Program, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland; Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland; Department of Neuroscience, Georgetown University Medical Center, Washington, DC., Natividad LA; College of Pharmacy, Division of Pharmacology and Toxicology, University of Texas at Austin, Austin, Texas., Haass-Koffler CL; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island; Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island; Carney Institute for Brain Science, Brown University, Providence, Rhode Island; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland., Martin-Fardon R; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Roberto M; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California. Electronic address: mroberto@scripps.edu.
Source: Biological psychiatry [Biol Psychiatry] 2022 Jun 15; Vol. 91 (12), pp. 1008-1018. Date of Electronic Publication: 2022 Apr 13.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0213264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2402 (Electronic) Linking ISSN: 00063223 NLM ISO Abbreviation: Biol Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35430085
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Varodayan+FP%22">Varodayan FP</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Developmental Exposure Alcohol Research Center and Behavioral Neuroscience Program, Department of Psychology, Binghamton University, State University of New York, Binghamton, New York.<br /><searchLink fieldCode="AU" term="%22Patel+RR%22">Patel RR</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Systems Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Matzeu+A%22">Matzeu A</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Wolfe+SA%22">Wolfe SA</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Curley+DE%22">Curley DE</searchLink>; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island; Neuroscience Graduate Program, Department of Neuroscience, Brown University, Providence, Rhode Island.<br /><searchLink fieldCode="AU" term="%22Khom+S%22">Khom S</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Gandhi+PJ%22">Gandhi PJ</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Rodriguez+L%22">Rodriguez L</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Bajo+M%22">Bajo M</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22D'Ambrosio+S%22">D'Ambrosio S</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Sun+H%22">Sun H</searchLink>; Clinical Core Laboratory, Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Kerr+TM%22">Kerr TM</searchLink>; College of Pharmacy, Division of Pharmacology and Toxicology, University of Texas at Austin, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Gonzales+RA%22">Gonzales RA</searchLink>; College of Pharmacy, Division of Pharmacology and Toxicology, University of Texas at Austin, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Leggio+L%22">Leggio L</searchLink>; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland; Medication Development Program, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland; Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland; Department of Neuroscience, Georgetown University Medical Center, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Natividad+LA%22">Natividad LA</searchLink>; College of Pharmacy, Division of Pharmacology and Toxicology, University of Texas at Austin, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Haass-Koffler+CL%22">Haass-Koffler CL</searchLink>; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island; Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island; Carney Institute for Brain Science, Brown University, Providence, Rhode Island; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Martin-Fardon+R%22">Martin-Fardon R</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Roberto+M%22">Roberto M</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California. Electronic address: mroberto@scripps.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220213264%22">Biological psychiatry</searchLink> [Biol Psychiatry] 2022 Jun 15; Vol. 91 (12), pp. 1008-1018. <i>Date of Electronic Publication: </i>2022 Apr 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0213264 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2402 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200063223%22">00063223 </searchLink><i>NLM ISO Abbreviation: </i>Biol Psychiatry <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35430085
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.biopsych.2022.02.006
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1008
    Titles:
      – TitleFull: The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Varodayan FP
      – PersonEntity:
          Name:
            NameFull: Patel RR
      – PersonEntity:
          Name:
            NameFull: Matzeu A
      – PersonEntity:
          Name:
            NameFull: Wolfe SA
      – PersonEntity:
          Name:
            NameFull: Curley DE
      – PersonEntity:
          Name:
            NameFull: Khom S
      – PersonEntity:
          Name:
            NameFull: Gandhi PJ
      – PersonEntity:
          Name:
            NameFull: Rodriguez L
      – PersonEntity:
          Name:
            NameFull: Bajo M
      – PersonEntity:
          Name:
            NameFull: D'Ambrosio S
      – PersonEntity:
          Name:
            NameFull: Sun H
      – PersonEntity:
          Name:
            NameFull: Kerr TM
      – PersonEntity:
          Name:
            NameFull: Gonzales RA
      – PersonEntity:
          Name:
            NameFull: Leggio L
      – PersonEntity:
          Name:
            NameFull: Natividad LA
      – PersonEntity:
          Name:
            NameFull: Haass-Koffler CL
      – PersonEntity:
          Name:
            NameFull: Martin-Fardon R
      – PersonEntity:
          Name:
            NameFull: Roberto M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 06
              Text: 2022 Jun 15
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2402
          Numbering:
            – Type: volume
              Value: 91
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Biological psychiatry
              Type: main
ResultId 1